Xyratex (Nasdaq: XRTX ) is expected to report Q4 earnings on Jan. 10. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Xyratex's revenues will wane -34.2% and EPS will shrink to a loss.
The average estimate for revenue is $255.2 million. On the bottom line, the average EPS estimate is -$0.32.
Last quarter, Xyratex tallied revenue of $275.7 million. GAAP reported sales were 24% lower than the prior-year quarter's $361.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.37. GAAP EPS of $0.28 for Q3 were 13% lower than the prior-year quarter's $0.32 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 18.5%, 180 basis points better than the prior-year quarter. Operating margin was 2.9%, 50 basis points worse than the prior-year quarter. Net margin was 2.8%, 10 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $1.15 billion. The average EPS estimate is $0.79.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 258 members out of 277 rating the stock outperform, and 19 members rating it underperform. Among 72 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 67 give Xyratex a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Xyratex is hold, with an average price target of $13.67.
Looking to profit from the makers of computer hardware? You may be missing something obvious about where the money will be made in the tech industry of the future. Is Xyratex on the right side of the revolution? Check out the changing landscape and meet the company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.
- Add Xyratex to My Watchlist.